CNTB Stock Analysis: Buy, Sell, or Hold?
CNTB - Connect Biopharma Holdings Limited Ordinary Shares
$2.04
-0.02 (-0.97%)
▼
5d:
+5.7%
30d:
-12.45%
90d:
-2.86%
WAIT
LOW Confidence
Analysis Updated: Sep 11, 2026 12:00 AM ET
Earnings: Aug 12, 2026
0d
Get Alerted When CNTB Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: CNTB shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: CNTB shows conflicting indicators. Wait for confirmation before entering.
In-depth Analysis How we analyze
Valuation Analysis: CNTB is currently trading at $2.04, which is considered oversold relative to its 30-day fair value range of $2.03 to $2.46.
Technical Outlook: Technically, CNTB is in a downtrend. Immediate support is located at $1.74, while resistance sits at $2.93.
Market Sentiment: CNTB scores 63/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $7.25 (+255.4%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, CNTB is in a downtrend. Immediate support is located at $1.74, while resistance sits at $2.93.
Market Sentiment: CNTB scores 63/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $7.25 (+255.4%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$2.03 -
$2.46
Company Quality Score
51/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
94.7%
All Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (63/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 255.4% below Wall St target ($7.25)
- WARNING: Composite score 51/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$2.03 -
$2.46
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$1.74
Resistance Level
$2.93
Current Trend
Downtrend
Technical data as of
Sep 11, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-2.28
Wall Street Target
$7.25
(+255.4%)
Revenue Growth (YoY)
5666.7%
Share & Embed Analysis
Last updated: September 13, 2026 9:27 AM ET
Data refreshes hourly during market hours. Next update: 10:27 AM
Data refreshes hourly during market hours. Next update: 10:27 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CNTB showing a specific setup today?
Insider Activity (6 Months)
1
Buys
0
Sells
+
Net
INSIDERS BUYING
Recent Transactions
James Huang
BUY
1160000 shares
2026-03-31
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BMRN
Biomarin Pharmaceutical … |
STRONG BUY
29 analysts |
$91 | 58 HOLD |
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
19 analysts |
$285 | 56 HOLD |
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
19 analysts |
$36 | 45 HOLD |
|
NRIX
Nurix Therapeutics Inc |
STRONG BUY
18 analysts |
$34 | 60 BUY |
|
BBIO
BridgeBio Pharma Inc |
STRONG BUY
19 analysts |
$109 | 57 HOLD |
